Medium dose level:1.0×10^6 UCAR+ T Cells/kg

2 trials

Sponsors

Zhongshan People's Hospital

Conditions

Advanced gliomasAdvanced gynecological tumor

Phase 1

Objective to evaluate the safety and efficacy of mesothelin ucar-t cell injection in the treatment of advanced gynecological tumors

RecruitingChiCTR2100042392

Zhongshan People's HospitalAdvanced gynecological tumor

Start: 2021-01-21Updated: 2021-04-26

Objective to evaluate the safety and efficacy of IL-13Ra2 ucar-t cell injection in the treatment of advanced glioma

RecruitingChiCTR2100042400

Zhongshan People's HospitalAdvanced gliomas

Start: 2021-01-21Updated: 2021-04-26